Sep 13, 2006

Metabolic safety of antihypertensive drugs: myth versus reality

Current Hypertension Reports
Sameer StasJames R Sowers

Abstract

Treatment of hypertension with the major available antihypertensive classes results in a significant improvement in cardiovascular morbidity and mortality. However, there is controversy about whether specific classes of drug therapy have deleterious or beneficial effects on glucose and lipid metabolism. Myths and misconceptions have thus arisen. Although "old" classes of antihypertensives, such as diuretics and beta-blockers, seem to have deleterious effects on glucose and lipid metabolism, the "newer" agents appear to have either neutral or beneficial profiles. The long-term significance of these metabolic changes is still debated. It is known that insulin resistance plays a major role in the pathogenesis of hypertension and type 2 diabetes mellitus. There is increasing evidence that blocking the renin-angiotensin-aldosterone system by using angiotensin-converting enzyme inhibitors or angiotensin-receptor blockers favorably affects insulin sensitivity and, accordingly, decreases the incidence of new-onset type 2 diabetes mellitus.

  • References45
  • Citations11

Citations

Mentioned in this Paper

Metabolic Process, Cellular
Diabetes Mellitus, Non-Insulin-Dependent
Pathogenic Aspects
Glucose Metabolism Disorders
Insulin Sensitivity
Pathogenesis
Selective Angiotensin II Receptor Antagonists
Insulin Resistance
Controlled Clinical Trials, Randomized
Angiotensins

About this Paper

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.